Press Releases & Media

Date Title and Summary Additional Formats
Toggle Summary PositiveID Announces 2017 Highlights and Projects Continued 30% Growth
Company expects year-over-year growth of over 30% for the 2017 fourth quarter and 2018 first quarter
View HTML
Toggle Summary PositiveID's ExcitePCR Subsidiary to Present and Exhibit at the Seed Central Tech Showcase on January 11th
Seed Central Showcase facilitates research collaboration between the seed and agbiotech industry and UC Davis to bring science to market faster Kimothy Smith , DVM, EVP and Chief Science Officer of ExcitePCR, will discuss how the company's FireflyDX can be used for agricultural screening DELRAY
View HTML
Toggle Summary PositiveID Corporation Discusses 2017 Accomplishments in New Interview with CEOLIVE.TV
Chairman and CEO William J. Caragol discusses projected consolidated year-over-year revenue growth of more than 30% for the 2017 fourth quarter and 2018 first quarter
View HTML
Toggle Summary PositiveID's ExcitePCR Named Major Player in Molecular Diagnostics Industry Report
ExcitePCR's FireflyDX is designed to bring lab-based testing to the point of need for real-time biological threat detection in less than 30 minutes
View HTML
Toggle Summary PositiveID Commences Production of Next Generation Caregiver Thermometer with Bluetooth Capability
Bluetooth-enabled Caregiver Device Holds Potential to Disrupt the $1 Billion Thermometry Market
View HTML
Toggle Summary PositiveID Projects Revenue Growth of More Than 30% Year-over-Year through First Quarter of 2018
Company Has a Strong Backlog of Business in its Mobile Labs and Medical Device Segments
View HTML
Toggle Summary PositiveID Corporation to Present at the LD MICRO "Main Event" Investor Conference on December 6th
DELRAY BEACH, Fla. , Nov. 27, 2017 (GLOBE NEWSWIRE) -- PositiveID Corporation ("PositiveID" or "Company") (OTC:PSID), a life sciences company focused on detection and diagnostics, announced today that its Chairman and CEO, William J. Caragol , will present at the LD MICRO 2017 "Main Event" investor
View HTML
Toggle Summary PositiveID Reports Third Quarter 2017 Results; Revenues increase 38% Year over Year
Company also improves operating results, reducing operating loss 74% for the third quarter of 2017 from the third quarter of 2016
View HTML
Toggle Summary PositiveID's ExcitePCR Subsidiary Publishes White Paper: PCR Unchained: The Coming Revolution in Field-Based Pathogen Detection
Company projects that a product like ExcitePCR's FireflyDX could transform the $28 billion global point-of-care diagnostics market
View HTML
Toggle Summary PositiveID's E-N-G Mobile Systems' Announces Incorporation of Advanced Drone Technology
ENG's new drone initiative to enable real-time communication in challenging environments and help deliver market edge
View HTML